Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Dermatological Treatment|June 20, 2022
Omalizumab is not just an anti-immunoglobulin EGoknur Ozaydin-Yavuz, Ibrahim Halil Yavuz, Hüseyin Serhat İnalöz, et al.
Mediators of Inflammation|October 5, 2023
Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous UrticariaCagdas Boyvadoglu, Hasan Ulusal, Seyithan Taysı, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 17, 2015
Association between isolated female acne and insulin resistance: a prospective studyDemet Kartal, Hatice Yildiz, Ragip Ertas, et al.
The Journal of Dermatological Treatment|July 8, 2025
Effects of platelet-rich plasma application on hair follicle count, telogen/anagen ratio, and miniaturized hair ratio in patients with androgenic alopecia: alone or in combination with other treatmentsFunda Koç Babayiğit, Demet Kartal, Salih Levent Çinar, et al.
Anais Brasileiros De Dermatologia|May 25, 2017
Effects of isotretinoin on the olfactory function in patients with acneDemet Kartal, Mehmet Yaşar, Levent Kartal, et al.
F1000Research|December 21, 2017
Case Report: A rare cause of oral bullae: Angina bullosa hemorrhagicaSalih Levent Cinar, Demet Kartal, Özlem Canöz, et al.
Postepy Dermatologii I Alergologii|August 12, 2016
Thyroid abnormalities in paediatric patients with vitiligo: retrospective studyDemet Kartal, Murat Borlu, Salih Levent Çınar, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 26, 2016
Lipoid proteinosisDemet Kartal, Salih Levent Çınar, Levent Kartal, et al.
International Journal of Dermatology|June 12, 2023
The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativaEda Öksüm Solak, Burcu Baran Ketencioglu, Salih L Cinar, et al.
Journal of Cosmetic Dermatology|March 16, 2024
Real-life data over 36 weeks of guselkumab treatment in psoriasis patients: A single-center study from TurkeyEda Öksüm Solak, Fatih Can Aba, Salih Levent Çınar, et al.
Pageof 3